ATE456957T1 - Methode und zusammensetzung zur behandlung diabetischer neuropathie - Google Patents

Methode und zusammensetzung zur behandlung diabetischer neuropathie

Info

Publication number
ATE456957T1
ATE456957T1 AT01991367T AT01991367T ATE456957T1 AT E456957 T1 ATE456957 T1 AT E456957T1 AT 01991367 T AT01991367 T AT 01991367T AT 01991367 T AT01991367 T AT 01991367T AT E456957 T1 ATE456957 T1 AT E456957T1
Authority
AT
Austria
Prior art keywords
diabetic neuropathy
compositions
composition
treatment
symptoms
Prior art date
Application number
AT01991367T
Other languages
English (en)
Inventor
Richard Rosenbloom
Original Assignee
The Quigley Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/740,811 external-priority patent/US6555573B2/en
Priority claimed from US09/847,121 external-priority patent/US20020165207A1/en
Application filed by The Quigley Corp filed Critical The Quigley Corp
Application granted granted Critical
Publication of ATE456957T1 publication Critical patent/ATE456957T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
AT01991367T 2000-12-21 2001-12-19 Methode und zusammensetzung zur behandlung diabetischer neuropathie ATE456957T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/740,811 US6555573B2 (en) 2000-12-21 2000-12-21 Method and composition for the topical treatment of diabetic neuropathy
US09/847,121 US20020165207A1 (en) 2001-05-02 2001-05-02 Compositions and methods for the treatment of diabetic neuropathy
PCT/US2001/049297 WO2002049575A2 (en) 2000-12-21 2001-12-19 Method and composition for the treatment of diabetic neuropathy

Publications (1)

Publication Number Publication Date
ATE456957T1 true ATE456957T1 (de) 2010-02-15

Family

ID=27113759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01991367T ATE456957T1 (de) 2000-12-21 2001-12-19 Methode und zusammensetzung zur behandlung diabetischer neuropathie

Country Status (11)

Country Link
EP (1) EP1351679B1 (de)
JP (1) JP4411414B2 (de)
AT (1) ATE456957T1 (de)
AU (2) AU2002231095B2 (de)
CA (1) CA2431079C (de)
DE (1) DE60141253D1 (de)
ES (1) ES2340363T3 (de)
IL (1) IL156549A0 (de)
MX (1) MXPA03005672A (de)
NZ (1) NZ526041A (de)
WO (1) WO2002049575A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
CA2470603A1 (en) * 2001-12-19 2003-07-03 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
FR2844716B1 (fr) * 2002-09-23 2008-11-21 Marcel Jacques Chicouri Nouvelles compositions pharmaceutiques destinees notamment a l'hygiene des pieds des diabetiques
DE10244282A1 (de) * 2002-09-23 2004-04-01 Merck Patent Gmbh Zubereitung mit antioxidanten Eigenschaften
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
EP1708689A2 (de) * 2003-12-29 2006-10-11 The President and Fellows of Harvard College Zusammensetzungen zur behandlung oder verhinderung von adipositas und insulin-resistenten erkrankungen
JP2006083138A (ja) * 2004-09-17 2006-03-30 Suntory Ltd アルドース還元酵素阻害剤
JP2006089399A (ja) * 2004-09-22 2006-04-06 Hajime Fukuda ２型糖尿病治療剤
JP2006298808A (ja) * 2005-04-19 2006-11-02 Hayashibara Biochem Lab Inc 痛覚刺激緩和剤
JP2006335752A (ja) * 2005-06-01 2006-12-14 Oriza Yuka Kk アルドース還元酵素阻害剤
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
EP1939166A1 (de) * 2006-12-19 2008-07-02 InterMed Discovery GmbH Pflanzenextrakte zur Verwendung in der Hirnmodulation
DE102007029042A1 (de) * 2007-06-21 2008-12-24 Analyticon Discovery Gmbh Pharmazeutische Zusammensetzung mit einem Trihydroxychromenone-Derivate
JP4932776B2 (ja) * 2008-04-16 2012-05-16 花王株式会社 油脂組成物
US8784911B2 (en) * 2009-11-05 2014-07-22 Korea Institute Of Oriental Medicine Compositions for treatment and prevention of diabetic complications using Osteomeles schwerinae
JP6151003B2 (ja) * 2012-10-26 2017-06-21 学校法人近畿大学 カンカニクジュヨウから得られる抗糖尿病剤、ヒト又は動物用医薬および機能性食品
KR101510257B1 (ko) 2013-12-30 2015-04-09 한림대학교 산학협력단 크리신(ｃｈｒｙｓｉｎ)을 유효성분으로 하는 당뇨합병성 신세뇨관 섬유화로 인한 신장섬유증 억제용 조성물
CN117298133B (zh) * 2023-11-30 2024-02-23 唐宁医药科技(济南)有限公司 归知糖疽有效成分配方在制备治疗糖尿病足药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250097A (en) 1978-03-08 1981-02-10 Syntex (U.S.A.) Inc. Compositions for and a method of preventing diabetic complications
FR2543550B1 (fr) * 1983-04-01 1985-08-09 Cortial Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique
US6103709A (en) * 1993-12-23 2000-08-15 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
GB9827391D0 (en) * 1998-12-11 1999-02-03 Fundation O N C F Aldose reductase inhibitors and pharmaceutical compositions
JP2002541116A (ja) * 1999-04-05 2002-12-03 ジーグラー，ランディー，エイチ 糖尿病の治療のための組成物及び方法
US6103756A (en) 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals

Also Published As

Publication number Publication date
DE60141253D1 (de) 2010-03-25
JP2004516257A (ja) 2004-06-03
AU3109502A (en) 2002-07-01
NZ526041A (en) 2005-01-28
JP4411414B2 (ja) 2010-02-10
EP1351679A4 (de) 2007-03-21
CA2431079C (en) 2010-02-09
WO2002049575A3 (en) 2003-07-24
EP1351679A2 (de) 2003-10-15
AU2002231095B2 (en) 2005-11-24
IL156549A0 (en) 2004-01-04
EP1351679B1 (de) 2010-02-03
WO2002049575A2 (en) 2002-06-27
ES2340363T3 (es) 2010-06-02
MXPA03005672A (es) 2004-12-03
CA2431079A1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
ATE456957T1 (de) Methode und zusammensetzung zur behandlung diabetischer neuropathie
MXPA04006039A (es) Metodo para el tratamiento de afecciones vasculares y neuronales perifericas.
ATE362363T1 (de) Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden
TW200639159A (en) Treatment of pain
HK1091481A1 (en) Therapeutic agents useful for treating pain
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
CR11037A (es) Derivados de 4-tetrazolil -4fenilpiperidina para tratar el dolor (divisional)
BR0108175A (pt) Derivados de piperazina e piperidina para o tratamento ou a prevenção de danos neuronais
BR0312232A (pt) Inibidores de caspases e seus usos
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
AU2001266289A1 (en) 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
AU2002357191A1 (en) Derivatives of isoindigo, indigo and indirubin and use in treating cancer
BRPI0417902A (pt) piperazinas úteis no tratamento da dor
DE60230155D1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
DE60229240D1 (de) Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes
WO2002053143A3 (en) Treatment of erectile dysfunction with rho-kinase inhibitors
ATE320797T1 (de) Verwendung von 6-dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz
ATE315387T1 (de) Verwendung von substituierten 6- dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz
DE69424679T2 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE250421T1 (de) Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties